Traditional Chinese medicinal preparation for treating retroperitoneal follicular dendritic cell sarcoma

Abstract

The invention discloses a traditional Chinese medicinal preparation for treating retroperitoneal follicular dendritic cell sarcoma. The traditional Chinese medicinal preparation is prepared from the following raw materials in parts by weight: 15-30 parts of hedyotis diffusa, 15-30 parts of herba patriniae, 15-30 parts of fructus forsythiae, 15-30 parts of dandelion, 10-20 parts of rhizoma curcumae, 10-20 parts of salviae miltiorrhizae, 10-20 parts of curcuma aromatica, 10-20 parts of rhizoma corydalis, 5-30 parts of pleione bulbocodioides, 15-30 parts of oysters, 5-30 parts of selfheal, 15-30 parts of carapax trionycis, 12-20 parts of poria cocos, 12-20 parts of atractylodes macrocephala koidz, 12-25 parts of angelica sinensis, 12-25 parts of yams and 12-25 parts of medlars. According to the traditional Chinese medicinal preparation disclosed by the invention, the hedyotis diffusa, the herba patriniae, the fructus forsythiae and the dandelion can clear heat and detoxify; the rhizoma curcumae, the salviae miltiorrhizae, the curcuma aromatica and the rhizoma corydalis can activate blood circulation to dissipate blood stasis; the pleione bulbocodioides, the oysters, the selfheal and the carapax trionycis can soften hard lumps and dispel nodes; the poria cocos, the atractylodes macrocephala koidz, the angelica sinensis, the yams and the medlars can strengthen and consolidate body resistance, tonify spleen and eliminate dampness; a traditional Chinese physician thinks that the sarcoma is mostly resulted from damp phlegm coagulation and is suitable to be treated by tonifying the spleen, eliminating dampness, reducing phlegm and resolving masses, so that multiple medicines are mixed in the preparation; the effect of treating the retroperitoneal follicular dendritic cell sarcoma is outstanding.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine preparation for treating retroperitoneal follicular dendritic cell sarcoma. Background technique [0002] Retroperitoneal follicular dendritic cell sarcoma is a neoplastic proliferation of spindle-shaped or oval cells morphologically and phenotypically characteristic of follicular dendritic cells. The age distribution is wide, most are adults, male and female are equal. Tumor cells generally express a non-neoplastic follicular dendritic cell phenotype and are biologically indolent, more like low-grade sarcomas. It is recorded in "Qian Jin Fang": "Don't treat sarcoma, treat it to kill, and be cautious", pointing out that sarcoma is extremely malignant and has a very poor prognosis. Modern medicine mainly treats this disease with radical resection, supplemented by radiotherapy and chemotherapy. However, after treatment, the recu...

AI Technical Summary

Problems solved by technology

Modern medicine mainly treats this disease with radical resection, supplemented by radiotherapy and chemotherapy, but after treatment, the recurrence and metastasis rates are high, the survival rate is low, and the prognosis is poor. Local recurrence occurs in 40% to 50% of cases.

Current drug treatments have disadvantages such as high cost, high toxicity and side effects, and poor curative effect.

So far, there is no drug with satisfactory curative effect on retroperitoneal follicular dendritic cell sarcoma at home and abroad